Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XASEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XASEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.3.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CN.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CN.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BG.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BG.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.576EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.576EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.637.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.637.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.79EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.79EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BG.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BG.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.3.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KN.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
KN.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.77EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.77EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.13.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.13.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HV.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.3.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.59EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BR.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BR.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.5.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CM.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBDEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used